LGND

LGND

USD

Ligand Pharmaceuticals Incorporated Common Stock

$189.200+1.000 (0.531%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$188.200

Hoch

$191.455

Tief

$186.280

Volumen

0.47M

Unternehmensfundamentaldaten

Marktkapitalisierung

3.7B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.23M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $93.58Aktuell $189.200Hoch $194.44

Ähnliche Nachrichten

Analyst Upgrades

Oppenheimer Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $250

Oppenheimer analyst Trevor Allred maintains Ligand Pharmaceuticals with a Outperform and raises the price target from $190 to $250.

Mehr anzeigen
Oppenheimer Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $250
GlobeNewswire

Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025

JUPITER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025. The company

Mehr anzeigen
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025